Wave Life Sciences Ltd. Stockholders Equity

Quick Answer

Wave Life Sciences Ltd. reported Stockholders Equity of $518.36 million for the year ending 2025.

  • Wave Life Sciences Ltd. showed an increase of +147.4% in Stockholders Equity from 2024 to 2025.
  • This data is from Wave Life Sciences Ltd.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q3 2015: -$3.12 million | Q1 2016: $146.52 million | Q2 2016: $166.28 million | Q3 2016: $151.13 million | Q1 2017: $117.09 million | Q2 2017: $188.91 million | Q3 2017: $165.86 million | Q1 2018: $110.05 million | Q2 2018: $139.30 million | Q3 2018: $106.61 million | Q1 2019: $196.86 million | Q2 2019: $160.22 million | Q3 2019: $114.77 million | Q1 2020: $20.86 million | Q2 2020: -$4.49 million | Q3 2020: $108.24 million | Q1 2021: $52.82 million | Q2 2021: $21.84 million | Q3 2021: $29.90 million | Q1 2022: -$53.0 thousand | Q2 2022: $30.95 million | Q3 2022: -$4.52 million | Q1 2023: -$34.71 million | Q2 2023: -$51.72 million | Q3 2023: -$40.49 million | Q1 2024: $25.39 million | Q2 2024: -$3.48 million | Q3 2024: $141.64 million | Q1 2025: $171.80 million | Q2 2025: $139.27 million | Q3 2025: $124.55 million.
  • Over the full 14 years of available data (2012 to 2025), Wave Life Sciences Ltd.'s Stockholders Equity has grown by 11,420.3%.
  • Historical annual values: Fiscal year 2025: $518.36 million | Fiscal year 2024: $209.52 million | Fiscal year 2023: $39.63 million | Fiscal year 2022: -$45.09 million | Fiscal year 2021: $32.50 million | Fiscal year 2020: $82.78 million | Fiscal year 2019: $63.73 million | Fiscal year 2018: $73.35 million | Fiscal year 2017: $139.61 million | Fiscal year 2016: $134.60 million | Fiscal year 2015: $153.49 million | Fiscal year 2014: $2.03 million | Fiscal year 2013: -$7.76 million | Fiscal year 2012: -$4.58 million.
  • Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: